PATENT CLAIM ANALYSIS

Application Number: 16170752
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "407000"]

Abstract:
Compounds are provided that act as potent antagonists of the CCR(9) receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR(9). The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR(9)-mediated diseases, and as controls in assays for the identification of CCR(9) antagonists.

Claim (Index 17):
The method of  claim 12 , wherein the CCR(9)-mediated disease or condition is an inflammatory bowel disease selected from Crohn's disease or ulcerative colitis.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 97.0
- Lexical Diversity: 1.73333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13781412', '10260008', '15383788', '11453221', '10533326']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.793256330853221
- 35 USC 102 Novelty (BERT): 0.553344028582315
- Combined Prediction Score: 0.7692651006261305
- Mean Citation Score: 314.8755920000001
- Max Citation Score: 409.82324
- Similarity Product: 364.927397499094

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test